Uber Sells 50% Stake in Careem’s Super App to e&
Cooley advised Uber, a tech company providing mobility as a service, on its agreement to sell a 50.03% stake in a newly created super app business unit of its Middle East subsidiary Careem to e& (formerly known as Emirates Telecommunications Group Company) for $400 million. Uber Sells 50% Stake in […]
Bavarian Nordic Acquires Emergent BioSolutions’ Travel Vaccines Portfolio
Bavarian Nordic, a vaccine company, has entered into a definitive agreement to acquire Emergent BioSolutions’ travel vaccines portfolio for up to $380 million, including an upfront payment of $270 million. Bavarian Nordic Acquires Emergent BioSolutions’ Travel Vaccines Portfolio
Justin Bieber to Sell Music Rights to Hipgnosis Songs for $200 Million
Cooley advised Justin Bieber in a $200 million deal to sell his music rights to Blackstone-backed Hipgnosis Songs Capital. Partners Michael Rhodes and Matt Hallinan led the Cooley team advising Bieber. Justin Bieber to Sell Music Rights to Hipgnosis Songs for $200 Million
World View to List in $350 Million SPAC Deal
Cooley advised World View, a leader in stratospheric exploration and flight, on its definitive business combination agreement with publicly traded special purpose acquisition company Leo Holdings Corp. II. World View to List in $350 Million SPAC Deal
Amryt Pharma to Sell to Chiesi Farmaceutici in $1.48 Billion Cross-Border Transaction
Cooley advised Amryt Pharma, a Dublin, Ireland-based commercial-stage biopharmaceutical company, on its definitive agreement to be acquired by Chiesi Farmaceutici, a Parma, Italy-based research-focused biopharmaceuticals and healthcare group, in a $1.48 billion cash and contingent value right (CVR) transaction. Amryt Pharma to Sell to Chiesi Farmaceutici in $1.48 Billion Cross-Border […]